(Q37299919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

Neuropsychiatric symptoms in dementia: importance and treatment considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Sarah Day

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sally Sharp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Gayle Wing

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Susanne Sorensen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

International Review of Psychiatry

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

396-404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18925489%20AND%20SRC:MED&resulttype=core&format=json

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Neuroleptic drugs in dementia: benefits and harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

A follow up study of depression in the carers of dementia sufferers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Sensory stimulation in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Nonpharmacological treatment of agitation: a controlled trial of systematic individualized intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Neuropathological correlates of behavioural disturbance in confirmed Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Hallucinations and associated factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Dementia with coexistent major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Lack of association between depression and loss of neurons in the locus coeruleus in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Donepezil for the treatment of agitation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Quetiapine for agitation or psychosis in patients with dementia and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Cholinergic deficits contribute to behavioral disturbance in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Functional analysis of challenging behaviour in dementia: the role of superstition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Behavioral alterations and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Evidence of a Monoaminergic-Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

A randomized trial of dementia care in nursing homes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

The occurrence of depression in Parkinson's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Behavioral treatment of depression in dementia patients: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Neuropathologic and neurochemical correlates of psychosis in primary dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Guidelines for the management of agitation in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968

Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260802099968